Studies for improving a rat model of Alzheimer's disease: ICV administration of well-characterized β-amyloid 1-42 oligomers induce dysfunction in spatial memory

Ágnes Kasza, B. Penke, Zsuzsanna Frank, Z. Bozsó, Viktor Szegedi, Ákos Hunya, Klaudia Németh, Gábor Kozma, L. Fülöp

Research output: Article

14 Citations (Scopus)

Abstract

During the past 15 years, several genetically altered mouse models of human Alzheimer's disease (AD) have been developed. These costly models have greatly facilitated the evaluation of novel therapeutic approaches. Injecting synthetic β-amyloid (Aβ) 1-42 species into different parts of the brain of non-transgenic rodents frequently provided unreliable results, owing to a lack of a genuine characterization of the administered Aβ aggregates. Previously, we have published a new rat AD-model in which protofibrillar-fibrillar Aβ 1-42 was administered into rat entorhinal cortex (Sipos 2007). In order to develop a more reliable model, we have injected well-characterized toxic soluble Aβ 1-42 species (oligomers, protofibrils and fibrils) intracerebroventricularly (icv) into rat brain. Studies of the distribution of fluorescent-labeled Aβ 1-42 in the brain showed that soluble Aβ-species diffused into all parts of the rat brain. After seven days, the Aβ-treated animals showed a significant decrease of spatial memory in Morris water maze test and impairment of synaptic plasticity (LTP) measured in acute hippocampal slices. The results of histological studies (decreased number of viable neurons, increased tau levels and decreased number of dendritic spines) also supported that icv administration of well-characterized toxic soluble Aβ species into rat brain provides a reliable rat AD-model.

Original languageEnglish
Article number2007
JournalMolecules
Volume22
Issue number11
DOIs
Publication statusPublished - nov. 1 2017

Fingerprint

oligomers
Oligomers
Amyloid
rats
Rats
Alzheimer Disease
brain
Brain
Data storage equipment
Poisons
rodents
Dendritic Spines
Entorhinal Cortex
Neuronal Plasticity
spine
cortexes
impairment
neurons
plastic properties
Neurons

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Studies for improving a rat model of Alzheimer's disease : ICV administration of well-characterized β-amyloid 1-42 oligomers induce dysfunction in spatial memory. / Kasza, Ágnes; Penke, B.; Frank, Zsuzsanna; Bozsó, Z.; Szegedi, Viktor; Hunya, Ákos; Németh, Klaudia; Kozma, Gábor; Fülöp, L.

In: Molecules, Vol. 22, No. 11, 2007, 01.11.2017.

Research output: Article

@article{2ae28139eeb247b5ad9e688953775c37,
title = "Studies for improving a rat model of Alzheimer's disease: ICV administration of well-characterized β-amyloid 1-42 oligomers induce dysfunction in spatial memory",
abstract = "During the past 15 years, several genetically altered mouse models of human Alzheimer's disease (AD) have been developed. These costly models have greatly facilitated the evaluation of novel therapeutic approaches. Injecting synthetic β-amyloid (Aβ) 1-42 species into different parts of the brain of non-transgenic rodents frequently provided unreliable results, owing to a lack of a genuine characterization of the administered Aβ aggregates. Previously, we have published a new rat AD-model in which protofibrillar-fibrillar Aβ 1-42 was administered into rat entorhinal cortex (Sipos 2007). In order to develop a more reliable model, we have injected well-characterized toxic soluble Aβ 1-42 species (oligomers, protofibrils and fibrils) intracerebroventricularly (icv) into rat brain. Studies of the distribution of fluorescent-labeled Aβ 1-42 in the brain showed that soluble Aβ-species diffused into all parts of the rat brain. After seven days, the Aβ-treated animals showed a significant decrease of spatial memory in Morris water maze test and impairment of synaptic plasticity (LTP) measured in acute hippocampal slices. The results of histological studies (decreased number of viable neurons, increased tau levels and decreased number of dendritic spines) also supported that icv administration of well-characterized toxic soluble Aβ species into rat brain provides a reliable rat AD-model.",
keywords = "AD rat model, Amyloid beta, Golgi staining, Hippocampus, Icv administration, Long-term potentiation, Morris water maze, Spatial memory",
author = "{\'A}gnes Kasza and B. Penke and Zsuzsanna Frank and Z. Bozs{\'o} and Viktor Szegedi and {\'A}kos Hunya and Klaudia N{\'e}meth and G{\'a}bor Kozma and L. F{\"u}l{\"o}p",
year = "2017",
month = "11",
day = "1",
doi = "10.3390/molecules22112007",
language = "English",
volume = "22",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "11",

}

TY - JOUR

T1 - Studies for improving a rat model of Alzheimer's disease

T2 - ICV administration of well-characterized β-amyloid 1-42 oligomers induce dysfunction in spatial memory

AU - Kasza, Ágnes

AU - Penke, B.

AU - Frank, Zsuzsanna

AU - Bozsó, Z.

AU - Szegedi, Viktor

AU - Hunya, Ákos

AU - Németh, Klaudia

AU - Kozma, Gábor

AU - Fülöp, L.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - During the past 15 years, several genetically altered mouse models of human Alzheimer's disease (AD) have been developed. These costly models have greatly facilitated the evaluation of novel therapeutic approaches. Injecting synthetic β-amyloid (Aβ) 1-42 species into different parts of the brain of non-transgenic rodents frequently provided unreliable results, owing to a lack of a genuine characterization of the administered Aβ aggregates. Previously, we have published a new rat AD-model in which protofibrillar-fibrillar Aβ 1-42 was administered into rat entorhinal cortex (Sipos 2007). In order to develop a more reliable model, we have injected well-characterized toxic soluble Aβ 1-42 species (oligomers, protofibrils and fibrils) intracerebroventricularly (icv) into rat brain. Studies of the distribution of fluorescent-labeled Aβ 1-42 in the brain showed that soluble Aβ-species diffused into all parts of the rat brain. After seven days, the Aβ-treated animals showed a significant decrease of spatial memory in Morris water maze test and impairment of synaptic plasticity (LTP) measured in acute hippocampal slices. The results of histological studies (decreased number of viable neurons, increased tau levels and decreased number of dendritic spines) also supported that icv administration of well-characterized toxic soluble Aβ species into rat brain provides a reliable rat AD-model.

AB - During the past 15 years, several genetically altered mouse models of human Alzheimer's disease (AD) have been developed. These costly models have greatly facilitated the evaluation of novel therapeutic approaches. Injecting synthetic β-amyloid (Aβ) 1-42 species into different parts of the brain of non-transgenic rodents frequently provided unreliable results, owing to a lack of a genuine characterization of the administered Aβ aggregates. Previously, we have published a new rat AD-model in which protofibrillar-fibrillar Aβ 1-42 was administered into rat entorhinal cortex (Sipos 2007). In order to develop a more reliable model, we have injected well-characterized toxic soluble Aβ 1-42 species (oligomers, protofibrils and fibrils) intracerebroventricularly (icv) into rat brain. Studies of the distribution of fluorescent-labeled Aβ 1-42 in the brain showed that soluble Aβ-species diffused into all parts of the rat brain. After seven days, the Aβ-treated animals showed a significant decrease of spatial memory in Morris water maze test and impairment of synaptic plasticity (LTP) measured in acute hippocampal slices. The results of histological studies (decreased number of viable neurons, increased tau levels and decreased number of dendritic spines) also supported that icv administration of well-characterized toxic soluble Aβ species into rat brain provides a reliable rat AD-model.

KW - AD rat model

KW - Amyloid beta

KW - Golgi staining

KW - Hippocampus

KW - Icv administration

KW - Long-term potentiation

KW - Morris water maze

KW - Spatial memory

UR - http://www.scopus.com/inward/record.url?scp=85035793008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035793008&partnerID=8YFLogxK

U2 - 10.3390/molecules22112007

DO - 10.3390/molecules22112007

M3 - Article

C2 - 29156571

AN - SCOPUS:85035793008

VL - 22

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 11

M1 - 2007

ER -